These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8232944)

  • 1. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.
    Matsuo F; Bergen D; Faught E; Messenheimer JA; Dren AT; Rudd GD; Lineberry CG
    Neurology; 1993 Nov; 43(11):2284-91. PubMed ID: 8232944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
    Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
    Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.
    Duchowny M; Pellock JM; Graf WD; Billard C; Gilman J; Casale E; Womble G; Risner M; Manasco P
    Neurology; 1999 Nov; 53(8):1724-31. PubMed ID: 10563619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures.
    Loiseau P; Yuen AW; Duché B; Ménager T; Arné-Bès MC
    Epilepsy Res; 1990 Nov; 7(2):136-45. PubMed ID: 2127016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
    Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.
    Schapel GJ; Beran RG; Vajda FJ; Berkovic SF; Mashford ML; Dunagan FM; Yuen WC; Davies G
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):448-53. PubMed ID: 8505632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.
    Boas J; Dam M; Friis ML; Kristensen O; Pedersen B; Gallagher J
    Acta Neurol Scand; 1996 Oct; 94(4):247-52. PubMed ID: 8937535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old.
    Piña-Garza JE; Elterman RD; Ayala R; Corral M; Mikati MA; Piña-Garza MJ; Warnock CR; Conklin HS; Messenheimer JA
    J Child Neurol; 2008 Aug; 23(8):853-61. PubMed ID: 18660469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
    Smith D; Baker G; Davies G; Dewey M; Chadwick DW
    Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures.
    Jawad S; Richens A; Goodwin G; Yuen WC
    Epilepsia; 1989; 30(3):356-63. PubMed ID: 2498073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
    Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
    Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
    Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
    Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
    Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.
    Sander JW; Patsalos PN; Oxley JR; Hamilton MJ; Yuen WC
    Epilepsy Res; 1990 Aug; 6(3):221-6. PubMed ID: 2272345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Marson AG; Baker GA
    Cochrane Database Syst Rev; 2000; (3):CD001909. PubMed ID: 10908514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Marson AG; Baker GA
    Cochrane Database Syst Rev; 2001; (3):CD001909. PubMed ID: 11687001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.